CIK 0001705843
- Non-accelerated filer
- Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271967997
- Phone
- +1 858-450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-06 | Kozicz-Stankiewicz Anna Ewa Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-05-06 | Nelson Kimberly K. Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-04-29 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +3,750 | $3.59 | $13K | 96,732 |
| 2019-04-29 | Voytas Daniel F Chief Science Officer | Sale | −3,750 | $16.31 | $61K | 92,982 |
| 2019-04-29 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,750 | 204,611 | ||
| 2019-04-02 | Blome James Chief Executive Officer | Sale | −2,582 | $16.65 | $43K | 154,136 |
| 2019-04-01 | Sahoo Manoj Chief Commercial Officer | Sale | −1,522 | $17.33 | $26K | 66,817 |
| 2019-03-26 | Blome James Chief Executive Officer | Sale | −2,582 | $17.87 | $46K | 156,718 |
| 2019-03-20 | Sahoo Manoj Chief Commercial Officer | Sale | −3,262 | $18.00 | $59K | 68,339 |
| 2019-03-19 | Sahoo Manoj Chief Commercial Officer | Sale | −5,068 | $18.00 | $91K | 71,601 |
| 2019-03-19 | Blome James Chief Executive Officer | Sale | −2,582 | $17.32 | $45K | 159,300 |
| 2019-03-14 | Ribeill Yves J Director | Sale | −4,980 | $16.33 | $81K | 40,020 |
| 2019-03-13 | Ribeill Yves J Director | Sale | −5,000 | $16.08 | $80K | 45,000 |
| 2019-03-12 | Blome James Chief Executive Officer | Sale | −2,582 | $16.58 | $43K | 161,882 |
| 2019-03-12 | Ribeill Yves J Director | Sale | −5,000 | $16.76 | $84K | 50,000 |
| 2019-03-11 | Ribeill Yves J Director | Sale | −5,000 | $17.39 | $87K | 55,000 |
| 2019-02-25 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +3,977 | $3.59 | $14K | 96,959 |
| 2019-02-25 | Voytas Daniel F Chief Science Officer | Sale | −3,977 | $16.00 | $64K | 92,982 |
| 2019-02-25 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,977 | 208,361 | ||
| 2019-02-08 | Koschak William Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 |
Page 23 of 27 · 525 trades